Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
a patient that went beyond 6 months for the second dose of Shingrix; This non-serious case was reported by a consumer via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: a patient that went beyond 6 months for the second dose of Shingrix). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 07-MAY-2025 The reporter (office staff) reported that the physician had a patient that went beyond 6 months for the second dose of Shingrix. He wanted a medial inquiry to answer if the patient needed to re-start the 2-dose series over or if the patient could just get the second dose even though it was past 6 months. Till the time of reporting the patient did not receive the second dose of Shingrix, which led to an incomplete course of vaccination.